Rituximab as a Treatment Option after Autologous Hematopoietic Stem Cell Transplantation in a Patient with Systemic Sclerosis

Systemic sclerosis (SSc) is an intractable autoimmune disease characterized by vasculopathy and organ fibrosis. Autologous hematopoietic stem cell transplantation (AHSCT) should be considered for the treatment of selected patients with rapid progressive SSc at high risk of organ failure. It, however...

Descripción completa

Detalles Bibliográficos
Autores principales: Gressenberger, Paul, Jud, Philipp, Kovacs, Gabor, Kreuzer, Sonja, Brezinsek, Hans-Peter, Guetl, Katharina, Muster, Viktoria, Kolesnik, Ewald, Schmidt, Albrecht, Odler, Balazs, Adelsmayr, Gabriel, Neumeister, Peter, Brcic, Luka, Zenz, Sabine, Weber, Kurt, Gary, Thomas, Brodmann, Marianne, Graninger, Winfried B., Moazedi-Fürst, Florentine C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305780/
https://www.ncbi.nlm.nih.gov/pubmed/34201939
http://dx.doi.org/10.3390/jpm11070600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305780/
https://www.ncbi.nlm.nih.gov/pubmed/34201939
http://dx.doi.org/10.3390/jpm11070600

Ejemplares similares